Navigation Links
Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
Date:11/13/2009

FARMINGDALE, N.Y., Nov. 13 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider. The agreement provides Xenith with the rights to sell exclusively in the UAE and other select markets and includes minimum purchase requirements.

Xenith, well known in the Middle East as an aggressive competitor, has built a solid reputation as a distributor of state-of-the-art medical devices and capital equipment, with special emphasis on surgery and oncology.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt(TM) bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.

The SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The SonicOne establishes a new standard in advanced wound care and ensures progress towards patient healing.

"Misonix is pleased
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
6. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Calif. , May 20, 2013   Life ... announced that its Applied Biosystems™ 3500 Dx and 3500xL ... Commission for Protection against Health Risks in ... a major extension of Life Technologies, capabilities to serve ... with Sanger -based solutions.  ...
(Date:5/20/2013)... BETHESDA, Md. , May 20, 2013  TNI ... diseases through the activation and mobilization of the body,s ... trading on the OTC Markets, OTCQB marketplace under the ... able to view the real-time Level II stock quotes ... Noreen Griffin , CEO of TNI BioTech, ...
(Date:5/20/2013)... 2013 Decision Resources, one of the ... and healthcare issues, finds that surveyed U.S. and ... effect on quality of life is among the ... level of subjectivity and variability of tests used ... state that it is difficult to differentiate therapies ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2
... , CINCINNATI, Sept. 11 Kendle (Nasdaq: ... research organization, today announced that its regulatory affairs experts ... the Regulatory Affairs Professionals Society (RAPS) Annual Conference and ... Convention Center in Philadelphia. Demonstrating its leadership position in ...
... , , ... schedule of events at the Cardiovascular Research Foundation,s (CRF) annual ... 21st to Friday, September 25th, in San Francisco, CA. at ... world,s largest events for those performing cardiac diagnostics and interventions. ...
Cached Medicine Technology:Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 2Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 3InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2
(Date:5/20/2013)... May 20, 2013 This summer, digital ... world will make the pilgrimage to San Diego, CA, ... Digital Health Summer Summit produced by Living ... unique forum to showcase the latest digital health innovations, ... and network with some of industry’s most brilliant thinkers ...
(Date:5/20/2013)... 2013 Adeptia Inc., a ... business process integration solutions, today announced the ... integration solution. Version 6.0 is the ... automates business processes involving data access, validation, ... user interaction for real-time decision-making and exception-handling. ...
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Although many ... physician on staff to help improve outcomes, new ... to patients. Since one-third of teaching hospitals ... in Europe staff a nighttime physician in the ... while siphoning doctors away from hospitals with fewer ...
(Date:5/20/2013)... In celebration of National Women’s Health ... achieved at The Feinstein Institute for Medical Research ... Advancing Women in Science and Medicine (AWSM) , hosted ... Scientists, educators, business and community leaders from the region ... women in science. , “Women face unique barriers ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... Childhood obesity can lead to type 2 diabetes, asthma, ... youth are likely to be obese as adults, experience ... incur higher healthcare costs. In an article published in ... of Preventive Medicine, researchers report that children living ...
... Oct. 27 HealthSouth,Corporation (NYSE: HLS ) today, ... is reaffirming its previously announced full year 2008,guidance and ... believes remain sound., In addition, HealthSouth noted the ... million in debt year to date,through October 27, 2008, ...
... Oct. 27 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... annual,BIO Investor Forum on Thursday, October 30, 2008 at ... in San Francisco, California., Steve Worland, Ph.D., President ... of Anadys and an update on its development,programs., ...
... Mich. To tackle the growing number of psychiatric cases in ... of Michigan State University doctors from the colleges of Osteopathic ... across the state via video conference. , On a ... up to 10 patients each from as far away as ...
... ANN ARBOR, Mich., Oct. 27 Parrish Medical ... implemented Clinical,Xpert CareFocus(TM) and Clinical Xpert Navigator which ... workflow solutions from the Healthcare business of,Thomson Reuters., ... patients,within a hospital and give clinicians access to ...
... even in combo, an effective long-term treatment , , MONDAY, ... methotrexate are safe and effective for long-term, continuous treatment ... In a three-year study that enrolled about 600 patients, ... methotrexate alone, others took etanercept alone, and another group ...
Cached Medicine News:Health News:Green neighborhoods may reduce childhood obesity 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 3Health News:Anadys Pharmaceuticals to Present at Bio Investor Forum 2Health News:MSU doctors bring much-needed psychiatric care to rural areas via technology 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 3Health News:Etanercept, Methotrexate Safe for Juvenile RA 2
Troutman tying forceps are curved, delicate, bullet shape, with tying platforms. Flat pattern. Ultra fine platforms ideal for 10-0 or 11-0 suture material. Platforms fully meet to hold suture firmly....
Fine tying forceps, standard with smooth jaws. For 7-0 to 9-0 sutures....
Tennant stainless steel tying forceps is extra delicate, straight with smooth jaws, 6 mm long platform, round handle with guide pin. For 9-0 to 11-0 sutures....
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: